A 70,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech innovation hub, LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. It offers fully permitted laboratory and office space for as many as 60 startups comprising approximately 200 scientists and entrepreneurs. LabCentral provides first-class facility and administrative support, skilled laboratory personnel, a domain-relevant expert speaker series ‒ as well as the other critical services and support that early-stage companies need to begin laboratory operations on day one. A private, nonprofit institution, LabCentral was funded in part by two $5 million grants from the Massachusetts Life Sciences Center, with support from its real-estate partner, MIT. Founding sponsors include Triumvirate Environmental and Johnson & Johnson Innovation. The first startups joined us in early November, with lab operations launching officially November 15, 2013. To accommodate demand for its growing startups, LabCentral, with support from Pfizer, Inc., opened LabCentral 610 in December 2017. With the addition of this 33,000 square-foot facility, capable of supporting up to six early- to mid-stage companies, by 2018, LabCentral will have capacity to serve a total of ~450 scientists and entrepreneurs in about 70 companies across its two-building campus. Our mission is to help create the next generation of powerhouse biotech companies by providing entrepreneurs and innovative life-sciences startups with the space and resources they need to test out, challenge, and nurture early ideas.